Rare essentials : drugs for rare diseases as essential medicines von STOLK, Pieter, WILLEMEN, Marjolein J. C, LEUFKENS, Hubert G. M

Volltext

Reasons for and Time to Discontinuation of Rimonabant Therapy: A Modified Prescription-Event Monitoring Study von Willemen, Marjolein J. C., Mantel-Teeuwisse, Aukje K., Buggy, Yvonne, Layton, Deborah, Straus, Sabine M. J. M., Leufkens, Hubert G. M., Egberts, Toine C. G.

Volltext

Cardiovascular and psychiatric risk profile and patterns of use in patients starting anti-obesity drugs von Willemen, Marjolein J. C., Mantel-Teeuwisse, Aukje K., M. Straus, Sabine M. J., Leufkens, Hubert G. M., Egberts, Antoine C. G., M. Sturkenboom, Miriam C. J.

Volltext

Reasons for and Time to Discontinuation of Rimonabant Therapy von Willemen, Marjolein JC, Mantel-Teeuwisse, Aukje K, Buggy, Yvonne, Layton, Deborah, Straus, Sabine MJM, Leufkens, Hubert GM, Egberts, Toine CG

Volltext

Rare essentials: drugs for rare diseases as essential medicines von Stolk, Pieter, Willemen, Marjolein JC, Leufkens, Hubert GM

Volltext

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase von Willemen, Marjolein J, Mantel-Teeuwisse, Aukje K, Straus, Sabine M, Meyboom, Ron H, Egberts, Toine C, Leufkens, Hubert G

Volltext

Psychiatric and Cardiovascular Comorbidities in Patients With Diabetes Mellitus Starting Antiobesity Drugs von Willemen, Marjolein J., Mantel‐Teeuwisse, Aukje K., Straus, Sabine M., Leufkens, Hubert G., Egberts, Antoine C.

Volltext